TrialAdvances in therapy2016

Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.

Kathrin Herrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.